330 related articles for article (PubMed ID: 6613835)
21. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Manolis AS; Uricchio F; Estes NA
Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
[TBL] [Abstract][Full Text] [Related]
23. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone treatment in patients with ventricular arrhythmias.
Prystowsky EN; Heger JJ; Miles WM; Zipes DP
Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
[TBL] [Abstract][Full Text] [Related]
25. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
[TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
28. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
[TBL] [Abstract][Full Text] [Related]
29. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Reddy CP; Kuo CS; Jivrajka V
Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
[TBL] [Abstract][Full Text] [Related]
30. Ten years of experience with amiodarone.
Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
[TBL] [Abstract][Full Text] [Related]
31. Amiodarone for refractory cardiac arrhythmias: 10-year study.
Leak D; Eydt JN
CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
[TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
Nademanee K; Hendrickson J; Kannan R; Singh BN
Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
[No Abstract] [Full Text] [Related]
33. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
[TBL] [Abstract][Full Text] [Related]
34. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
[TBL] [Abstract][Full Text] [Related]
36. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Raviele A; Di Pede F; Delise P; Piccolo E
G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients.
Belhassen B; Shapira I; Keren G; Laniado S
Eur Heart J; 1985 Mar; 6(3):266-75. PubMed ID: 4029184
[TBL] [Abstract][Full Text] [Related]
38. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Anderson JL
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
[TBL] [Abstract][Full Text] [Related]
39. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]